-
Revised guideline aims to strengthen global approach to development of new antibacterial medicines
Revised guideline aims to strengthen global approach to development of new antibacterial medicines
-
Revised guideline aims to strengthen global approach to development of new antibacterial medicines
Revised guideline aims to strengthen global approach to development of new antibacterial medicines
EMA has published a revision of its guideline on the evaluation of human medicines indicated for the treatment of bacterial infections for a six-month public consultation.
-
Human medicines: highlights of 2018
Human medicines: highlights of 2018
-
Human medicines: highlights of 2018
Human medicines: highlights of 2018
EMA recommended marketing authorisations for 84 medicines for human use in 2018.
-
Veterinary medicines: highlights of 2018
Veterinary medicines: highlights of 2018
-
Veterinary medicines: highlights of 2018
Veterinary medicines: highlights of 2018
EMA recommended marketing authorisations for 10 veterinary medicines in 2018.
-
Brexit preparations
Brexit preparations
-
Brexit preparations
Brexit preparations
EMA has published detailed guidance to help marketing authorisation holders for both human and veterinary medicines prepare for the United Kingdom’s withdrawal from the European Union in March 2019.
